Hyperglycemia attenuates myocardial preconditioning of remifentanil

Journal of Surgical Research

Volumn 174, Issue 2, 2012, Pages 231-237

  Kim, Hyun Soo ^a   Kim, So Yeon ^b   Kwak, Young Lan ^b   Hwang, Ki Chul ^b   Shim, Yon Hee ^b  

^a Ewha Womans University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

hyperglycemia; hypoxia reoxygenation injury; myocardial preconditioning; remifentanil

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; REMIFENTANIL;

ANIMAL CELL; ARTICLE; CALCIUM HOMEOSTASIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE CELL; HEART PROTECTION; HYPERGLYCEMIA; HYPOXIA; IMMUNOBLOTTING; IN VITRO STUDY; ISCHEMIC PRECONDITIONING; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REOXYGENATION;

ANALGESICS, OPIOID; ANIMALS; ANIMALS, NEWBORN; ANOXIA; APOPTOSIS; CALCIUM; CELL SURVIVAL; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HYPERGLYCEMIA; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCYTES, CARDIAC; PIPERIDINES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84859518270     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.01.018     Document Type: Article

References (40)

1. Bellodi G, Manicardi V, Malavasi V, et al. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 1989;64:885.
2. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000;355:773.
3. Pugliese G, Tilton RG, Williamson JR. Glucose-induced metabolic imbalances in the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 1991;7:35.
4. Sowers JR, Standley PR, Ram JL, et al. Hyperinsulinemia, insulin resistance, and hyperglycemia: Contributing factors in the pathogenesis of hypertension and atherosclerosis. Am J Hypertens 1993;6:260S.
5. Kersten JR, Schmeling TJ, Orth KG, et al. Acute hyperglycemia abolishes ischemic preconditioning in vivo. Am J Physiol 1998; 275:H721.
6. Taegtmeyer H, Goodwin GW, Doenst T, et al. Substrate metabolism as a determinant for postischemic functional recovery of the heart. Am J Cardiol 1997;80:3A.
7. Lazzeri C, Chiostri M, Sori A, et al. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: A prognostic indicator and a marker of metabolic derangement. J Cardiovasc Med (Hagerstown) 2010;11:7.
8. Kim HS, Cho JE, Hwang KC, et al. Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival. Eur J Pharmacol 2009;628:132.
9. Ricci C, Jong CJ, Schaffer SW. Proapoptotic and antiapoptotic effects of hyperglycemia: Role of insulin signaling. Can J Physiol Pharmacol 2008;86:166.
10. Anaya-Prado R, Toledo-Pereyra LH. The molecular events underlying ischemia/reperfusion injury. Transplant Proc 2002; 34:2518.
11. Schultz JE, Gross GJ. Opioids and cardioprotection. Pharmacol Ther 2001;89:123.
12. Tanaka K, Ludwig LM, Kersten JR, et al. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 2004; 100:707.
13. An J, Rhodes SS, Jiang MT, et al. Anesthetic preconditioning enhances Ca2+ handling and mechanical and metabolic function elicited by Na+-Ca2+ exchange inhibition in isolated hearts. Anesthesiology 2006;105:541.
14. Hannon JD, Cody MJ. Effects of volatile anesthetics on sarcolemmal calcium transport and sarcoplasmic reticulum calcium content in isolated myocytes. Anesthesiology 2002;96:1457.
15. Tani M. Mechanisms of Ca2+ overload in reperfused ischemic myocardium. Annu Rev Physiol 1990;52:543.
16. Peart JN, Gross ER, Gross GJ. Opioid-induced preconditioning: Recent advances and future perspectives. Vascul Pharmacol 2005;42:211.
17. Yu CK, Li YH, Wong GT, et al. Remifentanil preconditioning confers delayed cardioprotection in the rat. Br J Anaesth 2007; 99:632.
18. Zhang Y, Chen ZW, GirwinM, et al. Remifentanil mimics cardioprotective effect of ischemic preconditioning via protein kinase C activation in open chest of rats. Acta Pharmacol Sin 2005;26:546.
19. Kim HS, Chang WC, Hwang KC, et al. Effect of propofol on calcium homeostasis in hypoxia-reoxygenated neonatal rat cardiomyocytes. Eur J Pharmacol 2008;594:139.
20. Davidoff AJ, Ren J. Low insulin and high glucose induce abnormal relaxation in cultured adult rat ventricular myocytes. Am J Physiol 1997;272:H159.
21. Ren J, Gintant GA, Miller RE, et al. High extracellular glucose impairs cardiac E-C coupling in a glycosylation-dependent manner. Am J Physiol 1997;273:H2876.
22. Hausenloy DJ, Yellon DM. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 2006;70:240.
23. Tang X, Downes CP, Whetton AD, et al. Role of phosphatidylinositol 3-kinase and specific protein kinase B isoforms in the suppression of apoptosis mediated by the Abelson protein-tyrosine kinase. J Biol Chem 2000;275:13142.
24. Tsuruta F, Masuyama N, Gotoh Y. The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. J Biol Chem 2002;277:14040.
25. Dong JW, Zhu HF, Zhu WZ, et al. Intermittent hypoxia attenuates ischemia/reperfusion induced apoptosis in cardiac myocytes via regulating Bcl-2/Bax expression. Cell Res 2003;13:385.
26. Pan Z, Bhat MB, Nieminen AL, et al. Synergistic movements of Ca(2+) and Bax in cells undergoing apoptosis. J Biol Chem 2001; 276:32257.
27. Champattanachai V, Marchase RB, Chatham JC. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc. Am J Physiol Cell Physiol 2007;292:C178.
28. Chen H, Shen WL, Wang XH, et al. Paradoxically enhanced heart tolerance to ischemia in type 1 diabetes and role of increased osmolarity. Clin Exp Pharmacol Physiol 2006;33:910.
29. Schaffer SW, Croft CB, Solodushko V. Cardioprotective effect of chronic hyperglycemia: Effect on hypoxia-induced apoptosis and necrosis. Am J Physiol Heart Circ Physiol 2000;278:H1948.
30. Ebel D, Mullenheim J, Frassdorf J, et al. Effect of acute hyperglycemia and diabetes mellitus with and without short-term insulin treatment on myocardial ischaemic late preconditioning in the rabbit heart in vivo. Pflugers Arch 2003;446:175.
31. Frantz S, Calvillo L, Tillmanns J, et al. Repetitive postprandial hyperglycemia increases cardiac ischemia/reperfusion injury: Prevention by the alpha-glucosidase inhibitor acarbose. FASEB J 2005;19:591.
32. Gross ER, Hsu AK, Gross GJ. Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta. Diabetes 2007;56:127.
33. Huhn R, Heinen A, Weber NC, et al. Hyperglycemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: Cardioprotection can be restored by blocking the mitochondrial permeability transition pore. Br J Anaesth 2008; 100:465.
34. Kersten JR, Toller WG, Gross ER, et al. Diabetes abolishes ischemic preconditioning: Role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol 2000;278:H1218.
35. Weber NC, Goletz C, Huhn R, et al. Blockade of anesthetic-induced preconditioning in the hyperglycemic myocardium: The regulation of different mitogen-activated protein kinases. Eur J Pharmacol 2008;592:48.
36. Hadour G, Ferrera R, Sebbag L, et al. Improved myocardial tolerance to ischemia in the diabetic rabbit. J Mol Cell Cardiol 1998;30:1869.
37. Xu G, Takashi E, Kudo M, et al. Contradictory effects of short-and long-term hyperglycemias on ischemic injury of myocardium via intracellular signaling pathway. Exp Mol Pathol 2004;76:57.
38. Di Filippo C, Marfella R, Cuzzocrea S, et al. Hyperglycemia in streptozotocin-induced diabetic rat increases infarct size associated with low levels of myocardial HO-1 during ischemia/reperfusion. Diabetes 2005;54:803.
39. Marfella R, Di Filippo C, Esposito K, et al. Absence of inducible nitric oxide synthase reduces myocardial damage during ischemia reperfusion in streptozotocin-induced hyperglycemic mice. Diabetes 2004;53:454.
40. Aikawa R, Nawano M, Gu Y, et al. Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt. Circulation 2000;102:2873.